BaraSeen inches closer to Nomu, Revora eyes Saudi expansion

BaraSeen approved for Nomu listing: Radiation therapy operator BaraSeen Medical received the Capital Market Authority approval to register and offer 3.3 mn shares — representing 17.1% of its share capital — on Nomu, according to a Tadawul disclosure. The approval is valid for six months from 24 June.

Nomu’s pipeline is busy: MSGA finalized bookbuilding on its Nomu IPO last week, Qemah is considering a 30% offering within two years, and Ziorak, a Mayar Holding subsidiary, plans to submit its own CMA application to list 30% of its shares on the parallel market.

USD 2 mn for Saudi expansion

Revora raises USD 2 mn to expand its local footprint: Riyadh-based AI commerce startup Revora raised USD 2 mn in a seed round co-led by i2i Ventures and Oraseya Capital, with proceeds earmarked mainly for Saudi expansion, according to a press release. The round also saw participation from Anchorless Bangladesh, Conjunction Capital, F6 Ventures, Hi2 Global, Orbit Startups, and strategic angels including Salla co-founder Salman Butt and operators from Bolt, Mubadala, and EY.

The company — formerly known as MyAlice — develops AI tools that help e-commerce merchants automate sales and customer interactions. It operates in more than 21 countries and says revenue grew 10x after it moved its RHQ to Riyadh and shifted its focus to Saudi Arabia and the GCC in 2024. Revora was founded in 2021 by Shuvo Rahman and Daniyal Baig.